Coronary artery disease (CAD) is a significant global health problem, contributing to significant
morbidity and mortality. Percutaneous coronary intervention (PCI) is an efficient therapy for
treating CAD, but it carries the risk of iatrogenic endothelial injury, which contributes to vessel inflammation
and induction of in-stent restenosis. Therefore, developing novel methods for enhancing
re-endothelialization after PCI is highly needed. Endothelial progenitor cells (EPCs) can differentiate
into mature endothelial cells, and cell therapy with EPC may offer a novel way for accelerating reendothelialization.
In this review paper, we aimed to briefly describe EPCs and highlight their potential
therapeutic roles in in-stent re-stenosis and endothelial injury.